ME/CFS lacks standardised diagnostic criteria owing to variations in both inclusion and exclusion criteria across different diagnostic guidelines, and furthermore, there are currently no effective treatments available
Patients with conditions characterized by chronic inflammation, such as cardiovascular disease, metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD), or metabolic syndrome, should discuss how tirzepatide fits into their comprehensive management plan
If ease of use matters most, the BPC spray is a great pick
The usable window is 3 to 7 days when stored at 2 to 8C
Medicines to help the body make new blood cells
When combined with testosterone, which improves strength and coordination, this leads to better physical responsiveness and reduced risk of injury